Literature DB >> 23053883

Effect of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706.

Tao Wang1, Wen-Qiao Zang, Min Li, Na Wang, Yu-Ling Zheng, Guo-Qiang Zhao.   

Abstract

BACKGROUND: MicroRNAs play important roles in coordinating a variety of cellular processes. Abnormal expression of miRNAs has been linked to several cancers. However, the functional role of miR-451 in esophageal squamous cell carcinoma remains unclear. AIMS: The present study explored the effects of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706.
METHODS: Synthetic miR-451 mimics were transfected into EC9706 cells using Lipofectamine™ 2000. The expression of miR-451 was analyzed by RT-PCR and the expressions of Bcl-2, AKT and phosphorylated AKT were analyzed by Western blotting. The MTT assay, soft agar colony formation assay, transwell assay and FACS were used to assess the effect of miR-451 on EC9706 cell proliferation, invasion, metastasis and apoptosis. Tumor growth was assessed by subcutaneous inoculation of cells into BALB/c nude mice.
RESULTS: In comparison to the controls, a significant increase in the expression of miR-451 was associated with significantly decreased expressions of Bcl-2, AKT and p-AKT, and a significant increase in the apoptosis rate. The number of cell clones was significantly decreased by miR-451 expression, which also caused the inhibition of cell proliferation. The average number of cells penetrating the matrigel was significantly lower than the controls. Injection of miR-451 inhibited tumor growth in a xenograft model.
CONCLUSIONS: Upregulated expression of miR-451 induced apoptosis and suppressed cell proliferation, invasion and metastasis in the esophageal carcinoma cell line EC9706. In addition, injection of miR-451 inhibited tumor growth in a xenograft model of esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053883     DOI: 10.1007/s10620-012-2395-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

Review 1.  PAR-4 as a possible new target for pancreatic cancer therapy.

Authors:  Asfar S Azmi; Philip A Philip; Syed F Zafar; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

Review 2.  [Role of miRNA in the diagnosis, prognosis and treatment of esophageal cancer].

Authors:  Xiu-feng Cao; Su-qing Li
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2011-03

3.  Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib.

Authors:  Bridget N Fahy; Michael G Schlieman; Melinda M Mortenson; Subbulakshmi Virudachalam; Richard J Bold
Journal:  Cancer Chemother Pharmacol       Date:  2005-03-25       Impact factor: 3.333

4.  Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.

Authors:  Tetsuya Ueda; Stefano Volinia; Hiroshi Okumura; Masayoshi Shimizu; Cristian Taccioli; Simona Rossi; Hansjuerg Alder; Chang-gong Liu; Naohide Oue; Wataru Yasui; Kazuhiro Yoshida; Hiroki Sasaki; Sachiyo Nomura; Yasuyuki Seto; Michio Kaminishi; George A Calin; Carlo M Croce
Journal:  Lancet Oncol       Date:  2009-12-18       Impact factor: 41.316

Review 5.  MicroRNA regulation by RNA-binding proteins and its implications for cancer.

Authors:  Marieke van Kouwenhove; Martijn Kedde; Reuven Agami
Journal:  Nat Rev Cancer       Date:  2011-08-05       Impact factor: 60.716

6.  BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer.

Authors:  Melinda M Mortenson; Joseph G Galante; Oren Gilad; Michael G Schlieman; Subbulakshmi Virudachalam; Hsing-Jien Kung; Richard J Bold
Journal:  J Cell Biochem       Date:  2007-12-01       Impact factor: 4.429

7.  Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.

Authors:  Hua Zhu; Hao Wu; Xiuping Liu; Brad R Evans; Daniel J Medina; Chang-Gong Liu; Jin-Ming Yang
Journal:  Biochem Pharmacol       Date:  2008-06-24       Impact factor: 5.858

8.  p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK.

Authors:  Karen A Boehme; Roman Kulikov; Christine Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-27       Impact factor: 11.205

9.  MicroRNAs in human cancer: from research to therapy.

Authors:  Massimo Negrini; Manuela Ferracin; Silvia Sabbioni; Carlo M Croce
Journal:  J Cell Sci       Date:  2007-06-01       Impact factor: 5.285

10.  Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549).

Authors:  Hai-Bo Bian; Xuan Pan; Jin-Song Yang; Zhao-Xia Wang; Wei De
Journal:  J Exp Clin Cancer Res       Date:  2011-02-17
View more
  19 in total

1.  MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.

Authors:  Fei Zhang; Wei Huang; Meixia Sheng; Tielong Liu
Journal:  Tumour Biol       Date:  2014-11-13

2.  Serum miRNA expression in patients with esophageal squamous cell carcinoma.

Authors:  Beina Hui; Xin Chen; Lingyun Hui; Ruxing Xi; Xiaozhi Zhang
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

3.  Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma.

Authors:  Wenqiao Zang; Yuanyuan Wang; Yuwen Du; Xiaoyan Xuan; Tao Wang; Min Li; Yunyun Ma; Ping Li; Xudong Chen; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2013-11-22

4.  Retraction Note to: Effect of miR-451 on the Biological Behavior of the Esophageal Carcinoma Cell Line EC9706.

Authors:  Tao Wang; Wen-Qiao Zang; Min Li; Na Wang; Yu-Ling Zheng; Guo-Qiang Zhao
Journal:  Dig Dis Sci       Date:  2019-11       Impact factor: 3.199

Review 5.  Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Feras Zaiem; Fazlul H Sarkar
Journal:  Ann Transl Med       Date:  2014-06

6.  MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1.

Authors:  Wen-Qiao Zang; Xuan Yang; Tao Wang; Yuan-Yuan Wang; Yu-Wen Du; Xiao-Nan Chen; Min Li; Guo-Qiang Zhao
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

7.  MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer.

Authors:  Wentao Li; Wenqiao Zang; Pei Liu; Yuanyuan Wang; Yuwen Du; Xiaonan Chen; Meng Deng; Wencong Sun; Lei Wang; Guoqiang Zhao; Baoping Zhai
Journal:  Tumour Biol       Date:  2014-08-02

8.  microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinoma.

Authors:  Yan Tang; Wei Wan; Lijuan Wang; Shishun Ji; Juanjuan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

9.  MicroRNA overexpression increases cortical neuronal vulnerability to injury.

Authors:  Jessie S Truettner; Dario Motti; W Dalton Dietrich
Journal:  Brain Res       Date:  2013-08-13       Impact factor: 3.252

10.  Salivary microRNAs as promising biomarkers for detection of esophageal cancer.

Authors:  Zijun Xie; Gang Chen; Xuchao Zhang; Dongfeng Li; Jian Huang; Cuiqin Yang; Pingyong Zhang; Yuxuan Qin; Yifan Duan; Bo Gong; Zijun Li
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.